rs387907048
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3
The NM_020320.5(RARS2):āc.1024A>Gā(p.Met342Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000373 in 1,607,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M342I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_020320.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARS2 | NM_020320.5 | c.1024A>G | p.Met342Val | missense_variant | 12/20 | ENST00000369536.10 | NP_064716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARS2 | ENST00000369536.10 | c.1024A>G | p.Met342Val | missense_variant | 12/20 | 1 | NM_020320.5 | ENSP00000358549.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1455058Hom.: 0 Cov.: 29 AF XY: 0.00000414 AC XY: 3AN XY: 724244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
Pontocerebellar hypoplasia type 6 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2010 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 22, 2024 | Variant summary: RARS2 c.1024A>G (p.Met342Val) results in a conservative amino acid change located in the Arginyl-tRNA synthetase, catalytic core domain (IPR035684) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250688 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1024A>G has been reported in the literature as a compound heterozygous genotype in trans with a pathogenic variant (ClinVar) in at least 1 individual affected with features of Pontocerebellar Hypoplasia, Type 6 who has been subsequently cited by others (example, Rankin_2010, cited in Namavar_2011, Nishri_2016, Ngoh_2016, Aldinger_2019, Nevanlinna_2020). In this individual, despite the absence of respiratory chain defects, the MRI findings and lactic acidosis were felt to be consistent with PCH6 and only the RARS2 gene was analyzed. Further, a different missense variant at the same codon p.Met342Ile has been reported to be LP/P by at least 5 laboratories in ClinVar, supporting the clinical importance of this amino acid residue. These data do not allow firm conclusions about variant significance. In vitro functional analysis found this variant had no effect on protein localization or expression, however function was not assessed (example, Gonzlez-Serrano_2018). The following publications have been ascertained in the context of this evaluation (PMID: 31474318, 30006346, 20952379, 31536827, 27061686, 26970947, 20635367). No other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at